Cart is empty A collaborative group led by the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) and the Division of Clinical Pathology & Molecular Pathology, Hong Kong Sanatorium & Hospital (HKSH), have published their findings on the clinical importance of the Multidisciplinary Molecular Tumor Board (MTB) in delivering a Precision Cancer Medicine service.
Leave A Comment